Gapping down
In reaction to earnings/guidance:
- BNTX -3.4%
Other news:
- UBX -38.4% (results from phase 2 Envision study of UBX1325 in patients with wet age-related macular degeneration)
- ICPT -0.5% (files mixed securities shelf offering)
Analyst comments:
- FYBR -3.8% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- OLLI -2.8% (downgraded to Sell from Neutral at Citigroup)
- DISH -2.1% (downgraded to Neutral from Buy at UBS)
- URI -1.4% (downgraded to Underperform from Neutral at Robert Baird)
- CAT -1.2% (downgraded to Underperform from Neutral at Robert Baird)